Patrick J. Rudewicz
Papers
2
Total Citations
28
H-Index
2
About
Patrick J. Rudewicz is a pioneering figure in bioanalytical mass spectrometry, with a career defined by pushing the boundaries of single-cell analysis and pharmaceutical characterization. His research centers on developing high-resolution, sensitive methodologies to study drug action at the most fundamental biological level. A landmark contribution is his work on integrating confocal microscopy with high-resolution mass spectrometry to analyze live single cells, enabling the direct observation of drug uptake, metabolism, and drug-induced phospholipidosis. This approach, detailed in his most-cited 2020 paper (15 citations), addresses a critical gap in pharmacology by revealing how individual cell phenotypes—rather than population averages—dictate therapeutic response and toxicity. Earlier, Rudewicz established foundational techniques for minimizing matrix effects in nanoelectrospray infusion mass spectrometry, a key advancement for accurate quantification of drug candidates like SCH 211803 (2004, 13 citations). His work has profound implications for personalized medicine and toxicology, providing tools to understand why some cells survive treatment while others succumb. By championing single-cell resolution, Rudewicz has illuminated the hidden heterogeneity that governs drug efficacy and safety.
Research Focus
Key Achievements
Top Papers
- 1
- 2